Cellosaurus KP-N-YS (CVCL_1342)

Cell line name KP-N-YS
Accession CVCL_1342
Resource Identification Initiative To cite this cell line use: KP-N-YS (RRID:CVCL_1342)
Comments Part of: COSMIC cell lines project.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Neuroblastoma (NCIt: C3270)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_Y132 (KP-N-YS1n)CVCL_Y133 (KP-N-YS2s)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP


Yagi M., Sugimoto T., Mine H., Horii Y., Matsumura T., Sawada T., Abe T., Sano K., Goshi J., Takahashi K.
Basic calponin expressing human neuroblastoma cell line of KP-N-YS.
Hum. Cell 11:231-238(1998)

PubMed=11129446; DOI=10.1097/00019606-200012000-00007
Sugimoto T., Mine H., Horii Y., Takahashi K., Nagai R., Morishita R., Komada M., Asada Y., Sawada T.
Neuroblastoma cell lines showing smooth muscle cell phenotypes.
Diagn. Mol. Pathol. 9:221-228(2000)

Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A., Sugimoto T., Inazawa J.
PPM1D is a potential target for 17q gain in neuroblastoma.
Cancer Res. 63:1876-1883(2003)

PubMed=23268333; DOI=10.1016/j.canlet.2012.12.011
Sugimoto T., Gotoh T., Yagyu S., Kuroda H., Iehara T., Hosoi H., Ohta S., Ohira M., Nakagawara A.
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Cancer Lett. 331:115-121(2013)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cell line databases/resources CGH-DB; 82-1
CGH-DB; 9083-4
Cosmic-CLP; 946363
GDSC; 946363
Chemistry resources ChEMBL-Cells; CHEMBL3308266
ChEMBL-Targets; CHEMBL2366065
Gene expression databases GEO; GSM1670008
Polymorphism and mutation databases Cosmic; 946363